Discovery Partners International (San Diego, CA) has announced the appointment of Richard K. Brown as president of its IRORI subsidiary. Dr. Brown joined IRORI in 1996 as vice president of business development.

David N. Cook has joined Eligix (Medford, MA) as senior vice president of R&D. Dr. Cook was formerly vice president of commercialization for Cerus Corp.

Glenn L. Cooper has been named chairman of the board of Interneuron Pharmaceuticals (Lexington, MA), replacing Lindsay A. Rosenwald. Dr. Rosenwald will remain on the board. The company also announced the resignation from the board of Peter Barton Hutt.

Agilent Technologies (Palo Alto, CA) has named Alain Couder as COO. He was previously chairman, president, and CEO of Packard Bell NEC.

ILEX Oncology (San Antonio, TX) has announced the appointments of three senior corporate managers to new positions. Michael T. Dwyer, vice president and chief financial officer since 1998, has been promoted to senior vice president–administration, in addition to his continuing role as president and chief operating officer of the company's contract research services business. His successor is Gregory L. Weaver, senior director of finance and administration at ILEX for the past year. In addition, Ronald G. Tefteller has been promoted to vice president and general counsel. Mr. Tefteller was previously senior director of corporate development and general counsel.

Kiva Genetics (Mountain View, CA) has announced the appointment of Steven B. Lehrer as chief business officer. Mr. Lehrer was most recently at the Monsanto Group as co-leader of the strategic business team and president of several business units, including Integrated Protein Technologies, NSC Technologies, Wellbridge, and Lexant.

Anthony Martin has been appointed president and CEO of Invitrogen's (San Diego, CA) principal European subsidiary. Mr. Martin was previously a director of Invitrogen from 1995 to 1998 and has been a director of Invitrogen BV, the company's subsidiary in The Netherlands, since 1998. He was most recently chairman, president and chief executive officer of AZUR Environmental.

Nanogen (San Diego, CA) has announced the appointment of Michael Moore as senior vice president, operations and product development and general manager, replacing W.J. Kitchen. Most recently, Mr. Moore served as vice president and general manager at Hitachi Instruments. Additionally, president and COO Tina Nova has announced her decision to retire. Dr. Nova joined Nanogen in 1993 as its fourth employee. Chairman and CEO Howard Birndorf will assume the additional title of president.

George B. Rathmann has joined Hyseq (Sunnyvale, CA) as chairman of the board, replacing Robert D. Weist, who assumes the title of vice chairman. Dr. Rathmann was the co-founder and first chairman of Amgen in 1980, and in 1992 founded ICOS, where he served as chairman until this past January.

CyThera (San Diego, CA) has named Michael J. Ross president and CEO. Previously, Dr. Ross was the co-founder, president, and CEO of MetaXen, now part of Exelixis, as well as founding president and CEO of Arris Pharmaceutical, now Axys. In addition, Lutz B. Giebel has been named COO. Dr. Giebel was co-founder and vice president of research at MetaXen.

Eos Biotechnology (S. San Francisco, CA) has appointed John B. Whelan vice president and CFO and Anne E. Titterton vice president, legal and general counsel. Mr. Whelan was previously director, corporate development at Hewlett-Packard, while Ms. Titterton held the position of associate general counsel at DuPont Merck Pharmaceutical.

Paul L. Wood has been named senior vice president of research at Centaur Pharmaceuticals (Sunnyvale, CA). Dr. Wood previously served as senior vice president of research and preclinical development at Elan Pharmaceuticals.